MedTrace Logo

Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery

NCT03299270 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1004

Last updated 2019-05-09

No results posted yet for this study

Summary

Multicenter, international, prospective, observational study, designed to evaluate the postoperative results in terms of quality of life and functional recovery of elderly patients after major cancer surgery.

The global expected duration of the study is 3 years, during which cancer patients over 70 years old undergoing major surgery will be evaluated before and after the surgical intervention, at 30 days, 3- and 6-months follow-up. The study is non-for-profit. Given the observational nature of the study, the original treatment plan, as designed by each individual recruiting centre, will not be altered or affected by the study inclusion. Inclusion in the study does not imply any deviation from the current standard of practice, and no change is expected to the perioperative treatment at any point. Patients will be only asked to complete simple screening/assessment tests.

Conditions

  • Elderly
  • Solid Malignancy

Interventions

OTHER

Questionnaires

Quality of Life and Functional recovery questionnaires

Sponsors & Collaborators

  • European Society of Surgical Oncology

    collaborator OTHER

  • International Society of Geriatric Oncology

    collaborator OTHER

  • IRST (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori)

    collaborator UNKNOWN

  • AUSL ROMAGNA

    lead OTHER

Principal Investigators

  • Giampaolo Giampaolo, MD · AUSL Romagna

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-27
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • United States
  • Greece
  • Israel
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03299270 on ClinicalTrials.gov